欧盟EMA药品数据库(European Medicines Agency Authorisation of Medicines DataBase)
商品名称ProMeris Duo
适用类别Veterinary
治疗领域
通用名/非专利名称metaflumizone;amitraz
活性成分metaflumizone;amitraz
产品号EMEA/V/C/000108
患者安全信息No
许可状态Withdrawn
ATC编码QP53AD51
是否额外监管No
是否仿制药或hybrid药物No
是否生物类似药No
是否附条件批准No
是否特殊情形No
是否加速审评No
是否罕用药No
上市许可日期2006/12/19
上市许可开发者/申请人/持有人Pfizer Limited 
人用药物治疗学分组
兽用药物治疗学分组Ectoparasiticides for topical use, incl. insecticides
欧盟委员会决定日期2015/07/08
修订号7
治疗适应症For the treatment and prevention of infestations by fleas (Ctenocephalides canis and C. felis), and ticks (Ixodes ricinus, Ixodes hexagonus, Rhipicephalus sanguineus, Dermacentor reticulatus and Dermacentor variabilis), and treatment of demodicosis (caused by Demodex spp.) and lice (Trichodectes canis) in dogs. The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).
适用物种Dogs
兽用药物ATC编码QP53AD51
首次发布日期2015/07/08
最后更新日期2015/07/13
产品说明书https://www.ema.europa.eu/en/documents/product-information/promeris-duo-epar-product-information_en.pdf
公共评估报告https://www.ema.europa.eu/en/medicines/veterinary/EPAR/promeris-duo
©2006-2025 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase